Thyroseq V3 genomic classifier thyroid testing
Active Definitive Contract Awarded Last action
- Contract number
- 36C25026C0012
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $143,500
Award facts
- Opportunity
-
- Q301--ThyroSeq v3 Genomic Classifier Sole Source Notice Special Notice · 36C25025Q0934 · Posted Sep 15, 2025
- Contract value 37% obligated
-
- $143,500.00 Current, with exercised options
- $386,785.00 Potential, with all options
- Completion date 22% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46202, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $73,500 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $70,000 |
About this award
Veterans Integrated Service Network 10 awarded a $386,785 definitive contract to Cytopath Biopsy Lab Inc. for ThyroSeq V3 genomic classifier thyroid testing on October 3, 2025, as a sole-source procurement under FAR 13.106-1(b)(1)(i) exclusive licensing provisions.
The originating special notice, posted September 15, 2025, describes reference laboratory testing services for thyroid cancer risk assessment at the Richard L. Roudebush VA Medical Center. The contract operates on a firm fixed-price basis with a base year plus four one-year option years, extending through October 2, 2030. Place of performance is Indianapolis, IN.
The procurement proceeded without competition based on the exclusive nature of ThyroSeq V3 technology, which the contracting office determined is proprietary to Cytopath Biopsy Lab Inc. The special notice invited potential competitors to submit evidence by September 18, 2025, that competition would be advantageous to the government; the VA proceeded with sole-source award. NAICS code 621511 (Medical Laboratories) applies, with a size standard of $41.5 million.
Quick answers
Who was awarded contract 36C25026C0012?
36C25026C0012 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 3, 2025.
How much is contract 36C25026C0012 worth?
The government has obligated $143,500 on 36C25026C0012. Its potential value, with all options, is $386,785.
Was contract 36C25026C0012 competed?
The extent of competition for 36C25026C0012 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award